載入...
Incretins and selective renal sodium-glucose co-transporter 2 inhibitors in hypertension and coronary heart disease
Hyperglycemia is associated with an increased risk of cardiovascular disease, and the consequences of intensive therapy may depend on the mechanism of the anti-diabetic agent(s) used to achieve a tight control. In animal models, stable analogues of glucagon-like peptide-1 (GLP-1) were able to reduce...
Na minha lista:
| 發表在: | World J Diabetes |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Baishideng Publishing Group Inc
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4564814/ https://ncbi.nlm.nih.gov/pubmed/26380062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v6.i11.1186 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|